Cargando…
mRNA Network: Solution for Tracking Chemotherapy Insensitivity in Small-Cell Lung Cancer
BACKGROUND: Small-cell lung cancer (SCLC) has poor prognosis and is prone to drug resistance. It is necessary to search for possible influencing factors for SCLC chemotherapy insensitivity. Therefore, we proposed an mRNA network to track the chemotherapy insensitivity in SCLC. METHODS: Six samples o...
Autores principales: | Chen, Peixin, Wu, Shengyu, Yu, Jia, Tang, Xuzhen, Dai, Chunlei, Qi, Hui, Zhu, Junjie, Li, Wei, Chen, Bin, Zhu, Jun, Wang, Hao, Zhao, Sha, Liu, Hongcheng, Kuang, Peng, He, Yayi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492269/ https://www.ncbi.nlm.nih.gov/pubmed/34621500 http://dx.doi.org/10.1155/2021/2105176 |
Ejemplares similares
-
Retracted: mRNA Network: Solution for Tracking Chemotherapy Insensitivity in Small-Cell Lung Cancer
por: Healthcare Engineering, Journal of
Publicado: (2023) -
CD39: the potential target in small cell lung cancer
por: Chen, Shanhao, et al.
Publicado: (2020) -
The landscape of immune checkpoints expression in non-small cell lung cancer: a narrative review
por: Liu, Yu, et al.
Publicado: (2021) -
Collection on reports of molecules linked to epithelial-mesenchymal transition in the process of treating metastasizing cancer: a narrative review
por: Cai, Yiyi, et al.
Publicado: (2021) -
Curative efficacy might be an early predictor of prognosis in patients with small cell lung cancer treated with 2 cycles of platinum-based first-line chemotherapy
por: Zhu, Kaibo, et al.
Publicado: (2021)